Skip to main content

Cipla

Cipla Limited is a global pharmaceutical company based in India focused on the development, manufacturing, and distribution of generic and branded pharmaceutical products. The company produces therapeutic formulations across respiratory, cardiovascular, anti-retroviral, central nervous system, and anti-infective segments, alongside active pharmaceutical ingredients. Principal revenues are generated through branded generic prescription sales, over-the-counter health products, and bulk active ingredient manufacturing contracts. Cipla serves healthcare providers, retail pharmacy chains, hospitals, and public health organizations across India, North America, South Africa, and international markets. The enterprise holds a market-leading global position in respiratory therapies and anti-retroviral HIV treatments. Cipla Limited is headquartered in Mumbai, India, and its common shares are listed on the BSE Limited and the National Stock Exchange of India.

15 of the funds FundTelligence covers report a position in Cipla.

Legal name
CIPLA Ltd
Sector
Health Care
Country
India
Funds holding it
15

Funds holding Cipla

Showing the 8 largest of 15 funds holding it.

Loading...